Amyloid beta-42 (Aβ-42), neprilysin and cytokine levels. A pilot study in patients with HIV related cognitive impairments

K.M. Mothapo , F. Stelma , M. Janssen , R. Kessels
Journal of Neuroimmunology 282 73 -79

7
2015
Effects of heavy metal pollution in the Pilcomayo river system Bolivia, on resident human populations

K. A. Hudson-Edwards , J. R. Miller , D. Presto , P. J. Lechler
Journal De Physique Iv 107 ( 1) 637 -640

7
2003
Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.

Z. K. van Helmond , J. S. Miners , E. Bednall , K. A. Chalmers
Neuropathology and Applied Neurobiology 33 ( 3) 317 -327

22
2007
Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy.

J. S. Miners , E. Ashby , Z. Van Helmond , K. A. Chalmers
Neuropathology and Applied Neurobiology 34 ( 2) 181 -193

110
2008
CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology.

J. S. Miners , P. G. Kehoe , S. Love , H. Zetterberg
Alzheimer's Research & Therapy 11 ( 1) 81

57
2019
Exploring the putative role of kallikrein-6, calpain-1 and cathepsin-D in the proteolytic degradation of α-synuclein in multiple system atrophy

A. P. Kiely , J. S. Miners , R. Courtney , C. Strand
Neuropathology and Applied Neurobiology 45 ( 4) 347 -360

7
2019
Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease

Seth Love , J.Scott Miners
Brain Pathology 26 ( 5) 607 -617

40
2016
Oligomeric Aβ in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy

Zoë Van Helmond , James S Miners , Patrick G Kehoe , Seth Love
Brain pathology 20 ( 2) 468 -480

61
2010
Correction to: ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

Charles E Evans , James S Miners , Giulia Piva , Christine L Willis
Acta Neuropathologica 140 ( 5) 791 -791

2
2020
ORCA–Online Research@ Cardiff

Charles E Evans , James S Miners , Giulia Piva , Christine L Willis

2020
Correlation between levels of VEGF and insoluble Aβ (1-42) in the cerebral cortex in Alzheimer's disease

TL Thomas , SJ Miners , PG Kehoe ,
Neuropathol Appl Neurobiol 41 22 -22

2
2015
Genetic variation in MME in relation to neprilysin protein and enzyme activity, Aβ levels, and Alzheimer's disease risk.

Francesco Panza , Scott Miners , Scott Miners , Bernadette M McGuinness
International journal of molecular epidemiology and genetics 3 ( 1) 30 -38

10
2012
Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes

Scott Miners , Hannah Tayler , Jonathan A Prince , Patrick G Kehoe
American Journal of Translational Research 1 ( 2) 163 -177

115
2009
Biochemical Evidence Of Cerebral Hypoperfusion in Dementia: Associated With β-Secretase, Endothelin-1 And Arteriolosclerosis

Scott Miners , Hannah Tayler , Seth Love , Robert MacLachlan
American Association of Neuropathologists 95th Annual Meeting

2019
KIF5A and KLC1 expression in Alzheimer’s disease: relationship and genetic influences

Kelly Hares , Scott Miners , Neil Scolding , Seth Love
AMRC Open Research 1 1

2
2019
Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer's Disease.

Timo Grimmer , Oliver Goldhardt , Igor Yakushev , Marion Ortner
Neurodegenerative Diseases 19 ( 1) 43 -50

3
2019
UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: questionnaire and workshop proceedings

Aisling McFall , Tuuli M Hietamies , Ashton Bernard , Margaux Aimable
Journal of Cerebral Blood Flow and Metabolism 40 ( 7) 1402 -1414

2020
O5-06-05: EXPLORING ACE-2 AS A NOVEL THERAPEUTIC TARGET FOR ALZHEIMER'S DISEASE

Charles E. Evans , Scott Miners , Mark A. Good , Patrick G. Kehoe
Alzheimers & Dementia 14

1
2018
Cognitive impact of COVID-19: looking beyond the short term.

Scott Miners , Patrick G. Kehoe , Seth Love
Alzheimer's Research & Therapy 12 ( 1) 170 -170

188
2020